DTZ: Oxygenator, Cardiopulmonary Bypass

Product code DTZ, “Oxygenator, Cardiopulmonary Bypass” in FDA's classification database, is a Class II device type under 21 CFR 870.4350 (cardiopulmonary bypass oxygenator), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 255 clearances under DTZ, 74 of them since 2011.
Updated Oct 29, 2026 · Clearances from FDA’s 510(k) database, as of Oct 29, 2026
Product code
DTZ
Regulation
21 CFR 870.4350
Class
II
Panel
Cardiovascular
Clearances
255
Most recent
Sep 14, 2026
Median review, last 2 years
269 days
Third-party review
Not eligible
Implant
No

What it covers

A cardiopulmonary bypass oxygenator is a device used to exchange gases between blood and a gaseous environment to satisfy the gas exchange needs of a patient during open-heart surgery.

The identification in 21 CFR 870.4350, cardiopulmonary bypass oxygenator. FDA gives DTZ no definition of its own, so the regulation’s describes it.

FDA flags DTZ devices as life-sustaining or life-supporting.

Recent clearances

510(k)DeviceApplicantDecisionType
K261438HORIZON 8AF (Integrated OXY MODULE 8AF and Horizon CVR) (US5305)Eurosets S.R.LSep 14, 2026Traditional
K253838Lifemotion Disposable Membrane OxygenatorLifemotion Medical Technology Co., Ltd.Mar 16, 2026Traditional
K240934Quantum Perfusion Blood Oxygenator ECC VT160-E3 (VT160-E3); Quantum Perfusion Blood Oxygenator ECC VT200-E3 (VT200-E3); Quantum Perfusion Blood Oxygenator VT75- E3 (VT75- E3);Spectrum Medical S.R.L.Mar 12, 2026Traditional
K250821Horizon AF Plus System (Integrated A.L. One AF Plus OXYGENATOR and Horizon CVR) (US5300); A.L. One AF Plus OXYGENATOR (US5204); Horizon CVR (US5073)Eurosets S.R.LDec 12, 2025Traditional
K242503Trilly Pediatric Oxygenator with Integrated Arterial Filter (US5232)Eurosets S.R.LNov 24, 2025Traditional
K231982Quantum Perfusion Blood Oxygenator VT75-E1, Quantum Perfusion Blood Oxygenator VT75-E2Qura S.R.LSep 12, 2024Traditional
K240666Affinity Fusion Oxygenator with Integrated Arterial Filter and Balance Biosurface (BB811); Affinity Fusion Oxygenator with Integrated Arterial Filter and Cardiotomy/Venous Reservoir with Balance Biosurface (BB841); Affinity Fusion Oxygenator with Integrated Arterial Filter and Balance Biosurface NON STERILE (BB811-NS)Medtronic Perfusion SystemsJul 10, 2024Traditional
K241352Affinity NT Oxygenator and Uncoated Cardiotomy/ Venous Reservoir (541); Affinity NT Oxygenator with Balance Biosurface and Uncoated Cardiotomy/Venous Reservoir (541B)Medtronic, Inc.Jun 12, 2024Special
K231652D100 KIDS; D101 KIDSSorin Group Italia S.R.L.Nov 16, 2023Special
K231773Quantum Perfusion Blood Oxygenator with Integrated AF and Sensor VT75-C1U, Quantum Perfusion Blood Oxygenator with Integrated AF VT75-C2U, Quantum Perfusion Blood Oxygenator with Integrated AF and Sensor VT200-C1U, Quantum Perfusion Blood Oxygenator with Integrated AF VT200-C2U, Quantum Perfusion Blood Oxygenator with Integrated AF and Sensor VT160-C1UQura S.R.LNov 8, 2023Traditional
From FDA’s 510(k) database, as of Oct 29, 2026Export CSV (100 rows free · all 255 with a free account)

Clearances by year

74 DTZ 510(k)s were cleared from 2011 to Oct 29, 2026. Days to decision run from the day FDA received the 510(k) to its decision, including time on hold.

YearClearancesMedian days to decision
2026 (so far)3137
20252364
20243124
20235145
20222153
20215336
2020593
2019590
2018372
2017254
2016362
20159134
2014528
2013928
2012990
20114160

Who submits

18 applicants cleared a DTZ device since 2011. 61% of the clearances went to applicants in United States, then Italy (27%), Germany (5%) and United Kingdom (4%). By type: Traditional 62% and Special 38%.

ApplicantClearances since 2011
Sorin Group Italia S.R.L.17
Medtronic, Inc.15
Eurosets S.R.L7
Terumo Cardiovascular Systems Corporation6
Maquet Cardiopulmonary, AG5
Qura S.R.L4
Chalice Medical , Ltd.3
Medos Medizintechnik AG3

How FDA classifies it

Class II (special controls). The special control for this device is the FDA guidance document entitled “Guidance for Cardiopulmonary Bypass Oxygenators 510(k) Submissions.”

From 21 CFR 870.4350. Special controls are the requirements a 510(k) must show it meets.

Standards

21 CFR 870.4350 names no consensus standards. Check FDA’s recognized standards database, or ask which standards recent DTZ clearances declared.

Ask about DTZ

US FDA devices: 510(k), De Novo, guidance, 21 CFR

Questions about DTZ

What is FDA product code DTZ?

Product code DTZ, “Oxygenator, Cardiopulmonary Bypass” in FDA's classification database, is a Class II device type under 21 CFR 870.4350 (cardiopulmonary bypass oxygenator), reviewed by FDA's Cardiovascular panel. FDA's 510(k) database lists 255 clearances under DTZ, 74 of them since 2011.

How many 510(k) clearances are there under DTZ?

FDA’s 510(k) database listed 255 clearances under DTZ as of Oct 29, 2026, 74 of them decided since 2011; the most recent decision was Sep 14, 2026. The Predicate Finder searches the live database.

How long does FDA take to clear a DTZ 510(k)?

For the 5 DTZ clearances decided in the two years before Oct 29, 2026, the median time from FDA receiving the 510(k) to its decision was 269 days. That counts calendar days, including time the submission was on hold waiting for answers from the submitter.

Which companies have the most DTZ clearances?

Since 2011: Sorin Group Italia S.R.L. (17), Medtronic, Inc. (15), Eurosets S.R.L (7), Terumo Cardiovascular Systems Corporation (6) and Maquet Cardiopulmonary, AG (5). 18 applicants have cleared a DTZ device in that time.

Sources

  1. FDA product classification: DTZ · Product Classification database
  2. 21 CFR 870.4350: Cardiopulmonary bypass oxygenator · eCFR, as of Oct 27, 2026
  3. openFDA 510(k) query for DTZ · run Oct 29, 2026
  4. 510(k) Premarket Notification database · FDA, accessdata.fda.gov
Follow DTZGet an email when FDA clears, recalls or publishes guidance for DTZ devices.

Know what FDA already cleared.